In a move to safeguard the company’s dominant position in cancer, Merck said Thursday it will license a new cancer drug from ...

After-tax profit was 812 million euros compared with 740 million in the same period last year, Merck said Thursday. The ...

Modifi Bio’s innovative approach has the potential for treating some of the cancer types that are often most unresponsive to ...

Merck & Co Inc. (MRK) and LaNova Medicines Ltd., a privately held clinical-stage biotechnology company Thursday said Merck has ...

Merck KGaA on Thursday reported a gain of 11.9% in adjusted quarterly earnings, helped by temporarily lower spending on drug ...

Merck’s Food and Beverage Days starting November 17! Calling all food heroes to join us for a free two day online event to share knowledge around Food and Beverage regulations, chemical and ...

They will present their research at a Women Chemists Committee (WCC)/Merck half-day symposium and be recognized ... Medicinal, Analytical, Chemical Biology, Computational or Structural Chemistry, and ...

Germany's Merck KGaA has said it needs to double the ... electronics like liquid crystal display screens and semiconductor chemicals. That diversified model makes it a small player in pharma ...

While Merck's oral drug Molnupiravir has already been cleared by the United Kingdom to treat COVID-19, a Paraguayan laboratory has filed for its emergency registration in the South American ...

Merck KGaA is a science ... sector provides scientists with laboratory materials, technologies, and services. The Performance Materials sector offers specialty chemicals and materials for ...

It has invested $10m (€9m) to construct the new lab. SOD is a material ... Kim Woo-kyu, managing director of Merck Korea said, “Merck has acquired M Chemicals and opened the SOD application ...